AFFIRM-AHF (Follow-up)
A randomised, double-blind placebo controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron deficient patients admitted for acute heart failure (AFFIRM-AHF)
- Medicine
- ferric carboxymaltose
- Population
- Heart failure
- Phase
- IV
- Starting year
- 2016
- More information
- ClinicalTrials.gov